{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-013505","form_type":"8-K","ticker":"TENX","cik":"0000034956","company_name":"TENAX THERAPEUTICS, INC.","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.711876+00:00","generated_at":"2026-05-30T08:39:56.680856+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Stockholders approve 7.9M share increase in 2022 Stock Incentive Plan","bullets":["Approved Amendment No. 2 to 2022 Stock Incentive Plan, increasing authorized shares to 8,336,600 (7,935,912 new shares).","Vote: 1,176,335 for, 157,003 against, 3,849 abstentions; no broker non-votes.","Board approved amendment on Sept 6, 2024; stockholders approved on Oct 25, 2024.","Adjournment proposal also approved: 1,194,879 for, 139,002 against, 3,306 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-013505","json":"https://secwatch.observer/filing/0001654954-24-013505.json","markdown":"https://secwatch.observer/filing/0001654954-24-013505.md","text":"https://secwatch.observer/filing/0001654954-24-013505.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34956/000165495424013505/0001654954-24-013505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34956/000165495424013505/tenx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:39:56.680856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}